Phase II study of sunitinib malate in head and neck squamous cell carcinoma

By Choong Nicholas   Kozloff Mark   Taber David   Hu H.   Wade James   Ivy Percy   Karrison Theodore   Dekker Allison   Vokes Everett   Cohen Ezra  

Investigational New Drugs, Vol. 28, Iss. 5, 2010-10 ,pp. : 677-683

Springer Publishing Company

Access to resources Recommend Favorite

Sunitinib malate for the treatment of renal cell carcinoma

By Wood Lori  

Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 9, 2012-06 ,pp. : 1323-1336

Informa Healthcare

Access to resources Recommend Favorite

Phase 2 trial of sunitinib and gemcitabine in patients with sarcomatoid and/or poor-risk metastatic renal cell carcinoma

By  

Cancer, Vol. 121, Iss. 19, 2015-10 ,pp. : 3435-3443

Blackwell Publishing

Access to resources Recommend Favorite

Erratum to: Sunitinib malate in previously untreated, nonsquamous, non-small cell lung cancer patients over the age of 70 years: Results of a Phase II trial

By Reynolds Craig   Spira Alexander   Gluck Larry   Bradie-Muller Suzanne   Zhan Feng   Boehm Kristi   Asmar Lina  

Investigational New Drugs, Vol. 31, Iss. 6, 2013-12 ,pp. : 1628-1628

Springer Publishing Company

Access to resources Recommend Favorite

Phase I/II study of sunitinib malate in Japanese patients with gastrointestinal stromal tumor after failure of prior treatment with imatinib mesylate

By Shirao Kuniaki   Nishida Toshirou   Doi Toshihiko   Komatsu Yoshito   Muro Kei   Li Yinhua   Ueda Eiji   Ohtsu Atsushi  

Investigational New Drugs, Vol. 28, Iss. 6, 2010-12 ,pp. : 866-875

Springer Publishing Company

Access to resources Recommend Favorite